Chapter 7shodhganga.inflibnet.ac.in/bitstream/10603/33483/14/14... · · 2015-01-28Bhattacharya T. K., Ghosh M. N. and Subramanian S. S ... and therapeutic strategies for prevention

Chapter 7

Chapter- 7 References

REFERENCES

1. A. Hassid and L. Levine. Res. Commun. Chern. Pathol. Pharmacal.

18. 507 (1977).

2. A. R. Whorton. M. Smigel. J. A. Oates. J. C.Frolich. Biochem. Biophys.

Acta 529. 176 (1978): J. C. MeG iff and H. D. ltskovitz. Circ. Res. 33.

479 (1973): F. A. Kuchi. Jr. H. G. Oien. E.A.Ham. in Prostaglandins in

Cardiovascular and Renal Function. A. Scriabine. A. M. Lefer. F. A.

Kuehl. Jr .. Eds. (Spectrum. New York. 1980). p. 31.

3. A. Robert. Gastroenterology 56.765. (1974).

4. A. W. Ford-Hutchinson. M.A. Bray. M. V.Dois. M. E. Shipley. M. J. N.

Smith. Nature (London) 286. 264 (1980).

5. Abramson. S. B., and Weissmann. G. The mechanisms of action of

nonsteroidal antiinflammatory drugs. Arthritis Rheum., 1989, 32: 1-9.

6. Agarwal C. P.,Agentsactions, 12,298,1982.

7. Ali, M., Bagati, A and Gupta, J., Indian. J. Chern., (1995).

8. AminA. et al. (2005). "Chemopreventive activities ofTrigonella foenum

graecum (Fenugreek) against breast cancer''. Cell Biollnt 29 (8): 687-

94.

9. Ammon HPT, Mack. T., Singh G. B. and Safayhi. H. Planta Medica.,

1991,57,203.

10. Ammon HP, Mack T, Singh GB, Safayhi H. Inhibition of leukotriene B4

formation in rat peritoneal neutrophils by an ethanolic extract of the

gum resin exudates of Boswellia Serrata. Planta Medica., 1991; 57:

203-207.

171


11. Ammon HPT. Salai guggal Boswellia serrata: from a herbal medicine to

a specific inhibitor of leukotriene biosynthesis. Boswellia serrata:

67-70.

12. Arora R. B., Basu N., and Jain A. P. (1970) Chemical Pharmacological

and Toxicological Studies of Curcuma Longa (Turmeric) II Indo. Soviet

Sym. Chern. Nat. Products Including Pharmacal P. 133.

13. Arora R. B., Basu N., Kapoor V. and Jain A. P. (1971) Anti

Inflammatory Studies on Curcuma Longa (Turmeric). Indian J. Med.

Res. 59, 1289-1295.

14. Arora R B., KapoorV., Gupta S. K., and Sharma R. C. Indian J. Exp.

Bioi, 9, 403, 1971.

15. Ashershon, R.A., Cervera, R, D'cruz, D.P., Hugher, G.R.V. (1991)

16. Atal C. K., Gupta 0 P. and Singh G. B., Brit. J. Pharmacal, 74, 203,

1981.

17. Atal C. K., Singh G. B., Batra S., Sharma S., and Gupta 0. P., Indian J.

Pharmacal, 12,59, 1980.

18. Atal, C. K., Gupta, 0. P., Singh, G. B., (1981), Br. J. Pharm. 13,203.

19. B. Samuelsson and M. hamberg. in Prostaglandins Synthetase

Inhibitors. 11 J. (1974).

20. B. Samuelsson. J.Am. Chern. Soc. 87. 3011(1965); M. Hamberg and

B Samuelsson. Proc. Nat. Acad. Sci. U.S.A. 70. 899 (1973): D. H.

Nugteren and E. Hazelhof. Biochem. Biophys. Acta 326. 448 (1973).

21. Bakhle, Y S. and Botting. R. M., Mediat. lnflamm., (1996), 5, 305-323.

22 Barnes, P J, Fan Chung, K, Page, C.P.: Pharmacal Rev, 40(1 ), 49,

(1988).

23. Basch E. et al. (2003). "Therapeutic applications offenugreek". Altern

Med Rev 8 (1 ): 20-27.

24. Basu K. Das, Gupta B., Bhattacharya S. K., Curr. Sci. 40, 86, 1971.

172


25. Bellamy N, Nuchanan WW, Goldsmith CH, Campbell J, Stitt LW.

Validation study of WOMAC: A health status instrument for measuring

clinically important patient relevant out comes to antirheumatic drug

therapy in patients with osteoarthritis of the hip or knee. J Rheumatol

1988; 15:1933-40.

26. Benerjee, S., Wei, B., Hillman, K. (1988)7.1mmunol141,1150.

27. Bhalla T. N., Gupta M. B., and Bhargava K. P., J. Res. Indian Med., 6,

11' 1971.

28. Bhargava K. P., Biochem, Pharmacal, 18,531, 1969.

29. Bhargava K. P., Gupta M. B., Gupta G. B. and Mitra C. R., Indian J.

Med. Res., 58,724, 1970.

30. Bhargawa. P. P., (1963). Perf. Ess. Oil. Rec. 54,740.

31. Bhaskar Rao,A., Sisodia, P.; Ind. J. exp. Bioi., 24(14), 644, (1986).

32. Bhattacharya T. K., Ghosh M. N. and Subramanian S. S., Fitoterapia,

51 (5), 265, 1980, MedAromat. Plants.Abstr., 3(6), 8106-3264, 1981.

33 Bonta, I.L. in: Handbook of Experimental Pharmacology (Vane, JR.

Ferreira, S.H. -ed.,) Springer-Verlag, London, (1977).

34. Brandt K.D., Palmoski MJ. Effect of salicylates and other non-steroidal

anti-inflammatory drugs on articular cartilage. Am. J. Med. 1984;77:

65-69.

35. Budhiraja, R. D., Sudhir S. and Garg K. N., Ptanta Medica, 50, 134,

1984.

36. Burch, R. M., Weitzberg, M., Block, N. (1991) Proc. Natl. Acad. Sci.

(USA) pp- 88, 355.

37. Burden-Sanderson- 1988 From Adamim J. G. :Inflammation: an

introduction to the study of Pathology, London, 1909. Macmillan & Co.

Ltd.

38. C. A. Winter. E. A. Risley. G. W. Nuss. J. Pharmacal. Exp. Ther 141.

369 (1963). 173


39. C. G. Van. Arman. Clin. Pharmacal. Ther 16.900 (1974).

40. C. Takeguchi. and C. J. Sih. Prostaglandins 2. 169. (1972): R. V.

Tomlinson. H. J. Ringold. M.C. Qureshi. E. Forchielli. Biochem. Biophys.

Res. Commun. 46. 552 (1972).

41. Chandra, D. and Gupta, S. S., lndian.J. Med. Res., (1972), 60, 138.

42. Chang, J.W., Coleman, P.D., O'Banion, M. K. (1996) Prostaglandin G/

H symhase 2 (cyclooxygenase-2) mRNA expression is decreased in

Alzheimer's disease. NeurohioiAging 17:801-808.

43. Chattopadhyay R R, Indian J. of Exp. Bioi. Vol. 36, (1998), pp.

418-420.

44. Chattopadhyay R R, Indian J Physic. All Sci, 49(2) (1995) 82.

45. Chawla A. S., Handa S. S., Sharma A. K., and Kaith B. S., J. Sci.

Indus. Res.: 46,214, 1987.

46. Chawla A. S., Sharma A. K, Handa S. S. and Dhar K. L., Indian J.

Chemistry, 30(b), 773, 1991.

47. Chopra R. N., Chopra I. C, Handa K. L. and Kapur L. D., (1958).

Indigenous Drugs of India Pub :Academic Publishers, Calcutta, New

Delhi P. P. 528.

48. Chopra R.N., NayarS. L. and Chopra 1. C. (1956). Glossary of Indian

Medicinal Plants, Pub : Council of Scientific and Industrial Research,

New Delhi. P. P. 85.

49. Chopra R. N, Nayar S. L. and Chopra I. C, (1956), Glossary of Indian

Medicinal Plants, (1956). CSIR, New Delhi, P.39.

50. Caperton, E., Byers, V, Sohard, J. (1989)Arthritis Rheum, 32, 5130

51. Curcumin protects rats from liver-damage caused by toxins (J Pharm

Pharmacal 2000 Apr;52(4 ):437 -40; Carcinogenesis 2000

Feb;21(2):331-5).

174


52. Cryer, B., Feldman, M. (1992) Effects of non-steroidal

anti-inflammatory drugs on endogenous gastrointestinal prostaglandins

and therapeutic strategies for prevention and treatment of

non-steroidal anti-inflammatory drugs induced damage. Arch. Intern.

M 1.S2: 1145-1155.

53. D. H. Nugteren. Biochem. Biophys. Acta 380.299 (1975).

54. Dallegri, F., Ottonelio, L., Dapino, R, Sacchetti, C. (1992b ). Effect of

non-sieroidul anti-inflammatory drugs on the neutrophil promoted

inactivation of alpha-1 proteinase inhibitors. J. Rheitmatol. 19:

419-423.

55. Das SK, Sajwan N. Srivastava R, Singh V, Singh GK, Singh R, Pandey

SN. KGMC Index- A modified WOMAC index to evaluate response in

patients with osteoarthritis knee. JIRA 1998; 6:46-49.

56. De (1992). Pharmacognostic and phytochemical studies on

Anti-inflammatory and Anti-hepatotoxic activity of Ayurvedic drugs.

57. De Duve, C. Separation and Characterization of Subcellular Particles

(Harvey Lancet Series), 59 (1965) 49.

58. Dekel S, Falconer J, Francis MJO. The effect of anti-inflammatory

drugs on glycosaminoglycan sulphation in pig cartilage.

Prostaglandins Med 1980;4: 133-140.

59. Dennis T. J., (1980), Bull Med Ethno. Bot, Res', 1, 353.

60. Deshpande UR, Gadre SG, Raste AS, et al. Protective effect of tur

meric (Curcuma longa L.) extract on carbon tetrachloride-induced liver

damage in rats. Indian J Exp Bio11998 Jun;36(6):573-7, PMID: 7740

61. Dhanvantari Nighantu, Chowkamba publication : 113.

62. Dipasquale, G., Rassaert, G.( Richter, R., Welau, P., Tripp, L.:

Prostaglandins, 3, 741, (1973).

63. Dixon J. S. et Furst D. E., (Eds), New-york, pp. 363-427).

175


64. Dorai T, Cao YC, Dorai B, Buttyan R, KatzAE. Therapeutic potential of

curcumin in human prostate cancer. Ill. Curcumin inhibits

proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP

prostate cancer cells in vivo. Prostate. 2001 ;47(4):293-303.

65. Dr. Ramadasan K. (1994). Turmeric -A Gold Mine For Biological

Research Builet in- V SO.

66. Dubois, R.N., Abramson, S.B., Crofford, L, Gupta, R.A., Simon, L.S.,

Van de Putte, L.B.A. and Lipsky, P. E., FASEB J., (1998), 12,

1063-1073.

67. E. W. Horton. Nature (London) 200. 892 (1963).

68. E. A, Ham and M. Zanetti. unpublished observation.

69. E. A. Ham. V. J. Cirillo. M. E. Zanetti. T. Y. Shen. F. A. Kuchi. Jr. in

Prostaglandins in Cellular Biology. P. W. Ramwell and B. B. Pharris.

Eds. (Plenum. New York. 1972). pp. 345-352.

70. E. A. Higgs. S. Moncada. J. R. Vane. Prostaglandins 16. 153. (1978);

M. J. Peck and T. J. Williams. Br. J. Pharmacal. 62. 464P (1978): K.

Komoriya. H.Ohmori. H. Azuma. S. Kurozumi. Y Hashimoto K. C.

Nicolaou W. E. Burnette. R. L. Mzgold Prostaglandins 15. 557 (1978).

71. E. Anggard. S. 0. Bohman. J. E. Griffin Ill. C. Larsson. A. B. Maunsbach.

Acta Physiol. Scand. 84.231 (1972).

72. E. G. Lapetina and P. Cuatrecases. Proc. Natl, Acad. Sei. U.S.A. 76.

121. (1979).

73. E. J. Goetzl and F. F. Sun. J. Exp. Med. 150.406. (1979).

74. E. J. Goetzl. H. R. Hill. R. R. Gorman.Prostaglandins. in press.

75. E. M. Davidson. A. W. Ford-Hutchinson. M J.H. Smith. J. R. Walker.

Br. J. Pharmacal. 64. 437P (1978): T. J. Williams. Ibid 65. 517 (1979).

76. Edmonds J., Hughes G. Lecture Notes on Rheumatology. (1985),

Oxford., Blackwell scientific (New edition due in December 1992).

176


77. F. A. Kuehl. Jr .. ibid. 5. 325 (1974).

78. F. A. Kuehl. Jr .. J. L. Humes. J. Tarnoff. V. J.Cirilio. E. A. Ham.

Science 169. 883 (1970): F. A. Kuehl. Jr .. and J. L. Humes. Proc,

Nati.Acad. Sci. U.S.A. 69. 480-(1972).

79. Fourie T. G. and Snyckers F. 0., J. Nat. Prod. 52(5), 1129, 1989.

80. G. A. Higgs and J. A. Salmon. Prostaglandins 17. 737. (1979). R. A.

Sturge. D. B. Yates. D.Gordon. M. Franco. W. Paul. A. Bray J. Morley.

Ann. Rheum Do. 37. 315.(1978).

81. G. Kaley and R. Weiner. Ann. N. Y.Acad. Sci.180. 338 (1971).

82. Geetha T. and Varalakshmi P., Anti-inflammatory activity of lupeol and

lupeollinoleate in adjuvant-induced arthritis, FITOTERAPIA. Volume

LX IX, No. 1, (1998).

83. Ghatak, N. and Basu,N.Indian J. Expt.Biol., (1972), 10,235.

84. Ghoshals.Chatterjee D. C, Dutta S. K. and Bhattacharya S. K.(1970)

Steroidal Capugenins of the seeds ofTrigonella Foenum-Graecum

A re-investigation.lndian J. Pharm. ,32 (16), 176.

85. Girgune J, B. and Garg B. D., (1979) J. Sci. Res. (Bhopal). 1, 119.

86. Glenn, M. E., Bowman, B. J., Koslowske, T.C. : Biochem. Pharmacal.

Supply 27, (1968) (cited by Nataraja, K.V.).

87. Goodwin, J.S. (1984). The American J. Medicine 77(iA), 57.

88. Gopalkrishnan C., Shankaranarayanan D., Kameshwaran L and

Natarajan S., Indian J. Med. Res. 69,513, 1979.

89. Gopalkrishnan, C., Shankaranarayanan D., Nizamudeen, S. K. and

Kameshwaran L, Indian J. Med. Res. 71,940, 1980.

90. Gretzer, B, Ehrlich, K, Maricic, N., Lambrecht, N, Respondek, M,

Peskar, B.M. (1998) Selective cyclooxygenase-2 inhibitor and their

influence on the protective effect of a mild irritant in the rat stomach,

Br:. J. Pharmacol123: 927-935.

177


91. Guenther. ES., (1943)Am. Perfumer.45,41.

92. Gupta A, Gupta R, Lal B. Effect of Trigonella foenum graecum

(fenugreek) seeds on glycaemic control and insulin resistance in type

2 diabetes mellitus: a double-blind placebo controlled study. J Assoc

Physicians India . 2001 ;49: 1 057-1 061.

93. Gupta A., Saifi,A. Q., Modi N. T, Rao, S. S. and Mishra N., Indian J.

Pharmacal, 18 (2), 113, 1986.

94. Gupta I, Parihar A, Malhotra P, et al., Effects of Boswellia serrata gum

resin in patients with ulcerative colitis. Eur. J. Med. Res. 1997; 2:

37-43.

95. Gupta M. 8., Nath R., Srivastava N., Shankar K., Kishor K. and Bhargava

K. P., Planta Med., 39(2), 157, 1980.

96. Gupta, 0. P., Sharma, N., Chand, D., (1992). J. Pharmacal. Texico.

Methods. 29(4), 15.

97. Gupta, V. N., Ind. Drugs, 1987; 24: 221.

98. GururajA, Kelakavadi M, Venkatesh D et al. Molecular mechanisms of

anti-angiogenic effect of curcumin. Biochem Biophys Res Commun

2002 Oct4;297(4):934 2002.

99. H. Wagner. Search for new plant constituents with potential

antiphlogistic and anti allergic activity. Planta Medica 1989 : 235-241.

100. Haldar R. K, Neogi N.C. and Rathore R. S., Indian J. Pharmacal, 2,

26, 1970.

101. Hannan JM, Rokeya 8, Faruque 0, et al. Effect of soluble dietary fiber

fraction of Trigonella foenum graecum on glycemic, insulinemic,

lipidemic and platelet aggregation status of Type 2 diabetic model rats.

J Ethnopharmacol . 2003;88:73-77

102. Hart, C, Mod. Drug Discovery, (1999), 54-59.

103. Hawkey, C. J., Lancet, (1999), 353,307-314.

178


104. HemaD., Tidjani M, Bassene E. and Ponssel J. L., Plant Med. Phytother

20(3), 231.1986. Med.Aromat. Plants.Abstr. 9(4), 8704-2371, 1987.

105. Herschman, H. R., Biochem Biophys.Acta. (1996), 1299,125-140.

106. Hidaka H, lshiko T, Furunashi T et al. Curcumin inhibits interleukin 8

production and enhances interleukin 8 receptor expression on the cell

surface:impacgt on human pancrreatic carcinoma cell growth by

autocrine regulation. Cancer2002 Sep 15;96(6):1206-14 2002

107. Hurley, J. V. in: Muir's Textbook of Pathology, (Anderson, J.R -ed.)

ELBS/Edward Arnold, London, (1984).

108. I. FridovichAnnu. Rev. Biochem. 44. 147(1975): J M McCord and I.

Fridovich J. Bioi. Chern. 244. 6049 (1969): S Carson. E. E. Vogin W.

Huber. T. L. Schulte. Toxicoi.Appl. Pharmacal. 26. 184 (1973): F.

Edsmyr. U. Huber B. Menander. Curr. Ther Res. Clin. Exp. 19. 198

( 1976): Y Oyanagui. Biochem. Pharmacal. 25.1465 ( 1976).

109. lnsel, P. A. in: The Pharmacological Basis of Therapeutics (Gilman,

A. G., Rail. T.W., Nies, A. S., Taylor, P. ed.) Peragamon Press, New

York; 1 ,(1990).

110. J. B. Smith and A. L. Willis. Nature (London) New Bioi. 231.235.(1971):

111. J IRA- Journal of Indian Rheumatism Association vol-9 supplement-1

April- 2001.

112. J. L. Humes and M. Galavage. Unpublished observation.

113. J. L. Humes. C. A. Winter. S. J. Sadowski. F. A. Kuehl. Jr .. in press.

114. J. L. Humes. R. J. Bonney. L. Pelus. M. E. Dahlgren. S. J. Sadowski.

F. A. Kuchi Jr .. P. Davies. Nature (London) 269. 149 (1977).

115. J. M. Dayer. J. Breard. L. Chess. S. M. Krane J. Clin Invest. 64.

1386(1979), D. S. New. combe. J. V. Fahey. Y Ishikawa. Prustaglandins 13, 235 (1977).

116. K. Ohuchi. and L. Levine. Prostaglandins Med. 1. 421 (1978).

179


117. Kang BY, Chung SW, Chung Wet al. Inhibition of interleukin-12

production in lipopolysaccharide-activated macrophage by curcumin.

EurJ Pharmacol1999 Nov;384(2-3):191-51999

118. Kantor, T.G. (1987). 'The American J. Medicine 83 (S4b)-2.

119. Kaviarasan S, Vijayalakshmi K, Anuradha CV. Polyphenol-rich extract

of fenugreek seeds protect erythrocytes from oxidative damage. Plant

Foods Hum Nutr. 2004; 59: 143-147.

120. Kawamori T, Lubet R, Steele VE, et al. Chemopreventive effect of

curcumin, a naturally occurring anti-inflammatory agent, during the

promotion/progression stages of colon cancer. Cancer Res.

1999;59:597-601.

121. Kelly JS (1988). Mem. Med. Rev. 3:1.27-39.

122. Kaviarasan S. et al. (2006). "Fenugreek (Trigonella foenum graecum)

seed extract prevents ethanol-induced toxicity and apoptosis in Chang

liver cells". Alcohol Alcohol41 (3): 267-273.

123. Kirtikar K. R. and Basu B. D. (1980).1ndian Medicinal Plant Val-l Pub.

Bishen Singh Mahendrapal Singh. Dehradun, P. P. 700-701.

124. Kirtikar K Rand Basu, B. D. (1975). Indian Medicinal Plants Vol. IV.

Pub: Bishen Singh Mahendrapal Singh, Dehradun, P.P. 2423-2426.

125. Knaus U, Wagner H. Effects ofboswellicacid ofBoswellia serrata and

other triterpenic acids on the complement system. Phytomedicine

1996;3; 77-81.

126. Kubo M., Matsuda H., Tanaka M., Kimura Y., Okuda H., Higashino M.,

Tani. T., Namba K. andArehi S., Chem. Pharm. Bull. 32,2724. 1984.

127. Lee, K. H., Spencer M. R. Studies on mechanism of actions of

salicylates V: Effect of salicylic acid on enzymes involved in

mucopolysaccharide synthesis. J Pharmacal Sci. 1969 ; 58 : 464-468.

128. Leguesne M, Brandt K, Bellamy N, Moskowitz R, Menkes CJ, Pelletier

JP,Aitman R. Guidelines for testing slow acting drugs in osteoarthritis.

J Rheumatol1994; 21(suppl41): 65-73. 1so


129. Lipsky, P. E., (1999b) The clinical potential of COX-2 specific

inhibitors. Am. J. Med. 106: 51S-57S.

130. Luper S. A review of plants used in the treatment of liver disease: part

two. Altern Med Rev. 1999;4(3):178-188; 692.

131. M. Hamberg and B. Samuelsson. Proc. Natl. Acad Sci. U.S.A. 71

3400 (1974).

132. M. Hamberg. Biochem. Biaphys. Res. Commun. 49 720 (1972).

133. M. Hamberg. J. Svensson. B. Samuelsson. Proc. Natl. Acad. Sci.

U.S.A. 72.2994 (1975).

134. Madar Z. Stark AH. New legume sources as therapeutic agents. Br J

Nutr. 2002;88(suppi3):S287-S292.

135. M Hochberg: J Rheumatol18: 1438, 1991.

136. Mahajan B, (1993), Ph. D. Thesis, Jammu University, Jammu.

137. Mahajan B., Sethi V. K , Taneja S. C. and Dhar K. L., (1995),

Phytochemistry 39 (2),453.

138. Malandkar M.A., (1925) J. lnd.lnst. Sci., 8. 240.

139. Mangan, F. R., Flack, J. D. (1987) The American J. Medicine 83

(S4b)-6

140. McCarty MF (1988). Nutrition 21. San Diego, 50:6,507-10.

141. Mehta K, Pantazis P, McQueen T, Aggarwal 88. Anti proliferative effect

of curcumin ( diferuloylmethane) against human breast tumor cell lines.

Anticancer Drugs. 1997;8(5):470-481.

142. Meier R., SchulerW., Desaulles P. 1950. Experientia. 6,469-471.

143. Menon MK, Karr A. Analgesic and psychopharmacological effects of

the gum resin of Boswellia serrata. Planta Medica 1971; 4: 332-341.

144. Menon P. S, Gangabai, G. and Swarnalakshmi T. Indian Drugs, 19 (9),

345, 1982.

181


145. Miller, T. A., (1993) Protective effect of prostaglandins against gastric

mucosal damage. Am. J. Physiol. 245: G601-G623

146. Morham, S.G, Langenbach, R., Loftin, CD., Tiano, H. F., Vouloumano,

N., Jenette, J. C. (1995) Prostaglandin synthase-2 gene description

causes severe renal pathology in the mouce. Cell83: 473-482

147. Morreale P, Monopulo R, Galati M. Boccanera L, Saponati G, Bacchi

L. Comparison of the antiinflammatory efficacy of chondroitin sulfate

and diclofenac sodium in patients with knee osteoarthritis. J. Rheumatol

1996; 23:1385-91.

148. N.A. Plummer. C. N. Henshy. R. D. CampA. P. Warin. M. W. Greaves.

J. Invest. Dermatol. 68.246 (1977).

149. Nadkarni K. M. (1927). Indian Material Medica. Pub: K. M Nadkarni,

Bombay. P. P. 866-869.

150. Naik, S.R., Chatterjee, N. R. (1993).1ndian Drugs, 30, 1.

151. Naik, S.K, Sheth, U.K. (1978).1nd. J. Exp. Bioi., 16, 1175.

152. Nataraja, K. V.: An Investigative Study of the Anti-Inflammatory

Activity of the Bark Extracts ofSaraca Indica, Linn (Ashoka)., Ph.D.

Thesis, University of Madras, Madras, (1985).

153. Newbould, B. B. (1963) Br. J. Pharmac. Chemother. 21, 127.

154. Nishikaze, 0., Furuyae, E and Kawamura, M. lnt J. tiss Reac, 7

(1985) 1.

155. NoackW, FischerM, Forster KK, Rovati LC, Setnikar I. Glucosamine

sulfate in osteoarthritis of the knee. Osteoarthritis Cart. 1994;2:51-59.

156. O'Duffy, J.D., Luthra, H.J. (1984) Drugs 27, 373.

157. Obolentseva G. V., and Khadzhai Ya 1., Zdorovya Kiev., 1.85. 1964;

Bioi.Abstr. 47,52478, 1966.

158. Ohnuma N, Yamaguchi E, Kawakami YAnaphylaxis to curry powder.

Allergy. 1998; 53:452-454.

182


159. Orient Longman, Indian Medicinal Plants; 1993; 1 :267.

160. P. Borgeatand B. Samuelsson. J. Bioi. Chern. 254.7865 (1979).

161. P. Davies. R. J. Bonney. J. L. Humes. F. A. Kuehl. Jr .. Inflammation 4.

335 (1977).

162. P. Graf. M. Glatt. K. Brune. Experientia. 31. 951 (1975).

163. Pachnanda, Ind. J. Pharmacol., 1981; 13:63.

164. PalS. and Nag ChaudhariA. K., 527, 1990.

165. Palmoskil JJ, Brandt KD (1980). Arthritis and Rheumatism 23:1010

166. Palmowski MJ, Brandt KD. Effect of salicylate on proteoglycan

metabolism in normal canine articular cartilage in vitro. Arthritis Rheum

1979;22:746-754.

167. Pandian RS, Anuradha CV, Viswanathari P. Gastroprotective effect of

fenugreek seeds ( Trigonella foenum graecum ) on experimental

gastric ulcer in rats. J Ethnopharmacol. 2002;81 :393-397.

168. Pandit Vishanath Bhavaprakasha Nighanthu, Motilal Banarasidas

publication, 1988, 32.

169. Pardhy R. S. and Bhattacharya. S. C, (1978). Ind. J. Chern. 16 (B),

171-176.

170. Parmar N. S. and Ghosh M. N., Indian J. Pharmacol. 10,277, 1978

171. ParmarN. S. and Ghosh M. N., Indian J. Pharmacol12, 201, 1980

172. Parmar, N. S. (1977) in: A pharmacological study on the effect of

some Bioflavonoids on Experimentally induced Inflammation, Increased

Vascular Permeability, Gastric Ulcers and Galactosemic Catarrets,

Ph.D., Thesis. University of Madras, Madras.

173. Pasinetti, G.M.,Aisen, P.S. (1998) COX-2 expression is increased in

frontal cortex of Alzheimer's disease brain. Neuroscience 87:319-324

174. Pearson R. S. and Singh. P., (1918) Indian Forest Records, 6, 321.

183


175. Pearson C. M. Wood F. D. (1959) studies on Polyarthritis and other

lesions indoced in rats by injection of mycobacterium adjuvant. Arthr

Rheum. 2, 440-45-9.

176. Perper R. J., Alvarez B. Colombo C. Schroder it (1971). The useof

standardized adjuvant arthritis assay to differentiate between anti

inflammatory and immunosupressive agents Proc. Soc. Exp. Bio. Med.

137:506-512.

177. Pillai, N. R., and Santhakumari G., Planta Med., 43 (1), 59, 1981.

178. Prabhakar M. C, Bano H., Kumar 1., Shamsi M.A., and Khan M.S. Y,

Planta. Med.; 43,396, 1981.

179. Prakash K. Pispati, Joy Philip, Siddharth DAS, Indian rheumatism

association, Arthritis and rheumatism, Pfizer.

180. R. B. Zurier. S. Hoffstein. G. Weissmann. Arthritis Rheum. 16. 606

(1973).

181. R. C. Murphy. S. Hammarstrom. B. Samuelsson. Proc. Natl. Acad.

Sci. U.S.A. 76. 4275 (1979).S. Hammarstrom. R. C. Murphy. B. Samuel

ssonD. A. Clark. C.Mioskowski E. J Corey. Biochem. Biophys. Res.

Commun, 91. 1266 (1979).

182. R. Gryglewski. in Prostaglandins Synthetase Inhibitors. H. J. Robinson

and J RVane. Eds.(Raven. New York. 1974). p. 33.

183. R. J. Bonney P. D. Wightman. P. Davies. S. Sadowski F. A Kuehl. Jr.

J. L. Humes Biochem. J. 176.433. (1978).

184. R J. Bonney. P Naruns. P. Davies. J. L. Humes Prostaglandins 18.665

(1979).

185. R. J. Flower and G. J. Blackwell Nature (London) 278.456 (1979).

186. R. J. Flower and G. J. Blackwell. Biochem. Pharmacol. 25.285 (1976).

187. R. J. Flower Naunyn-Schmiedebergs's Arch.Pharmacol. 297. S77

(1977).

184


188. R. J. Flower. Pharmacal. Rev. 26. 33 ( 197 4 ):M.I. Siegel. R T. McConnell

P Cuatrecasas. Proc. Natl. Acad. Sci. U.S.A. 76. 3774 (1979): H. S.

Kantor and M. Hampton. Nature (London) 216. 841. (1978): S. Ri

Henhouse- SimonsJ. Bioi. Chern 255.2259(1980).

189. R. J. Greglewski. B. Panezenko. R. Korbut. L. Grodzinska. A.

Ocetkiewicz. Prostaglandins W. 343 (1975).

190. Rail B, Ammon HPT, Safayhi H. Boswellic acids and protease activities.

Phytomedicine 1996;3;75-76.

191. Raju J. et al. (2004 ). "Diosgenin, a steroid saponin ofTrigonella foenum

graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt

foci formation in F344 rats and induces apoptosis in HT -29 human

colon cancer cells". Cancer Epidemiol Biomarkers Prev 13 (8):

1392-1398.

192. Raju J. and R.P. Bird et al. (2006). "Alleviation of hepatic steatosis

accompanied by modulation of plasma and liver TNF-alpha levels by

Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa)

rats". International Journal of Obesity 30 (8): 1298-1307.

193. Ramirez-Tortosa MC, Mesa MD,Aguilera MC, etal. Oral administration

of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic

effects in rabbits with experimental atherosclerosis. Atherosclerosis.

1999; 14 7(2):371-378.

194. Rao, T. S., Basu, N. and siddiqui, H. H, Indian J. Meet Res., (1982),

75,574.

195. Ravishankar B. Makwana H. G., Dodia U. A., Shukla V. J., and Santani

D. D. (2000) Experimental Techniques for Evaluating

Anti-inflammatory activity and its mechanism of Action -A Review.

196. Raz, A., Wyche, A., Siegel, N. and Needleman, P. J. Biola. Chern.

(1988), 263,3022-3028.

185


197. Reasor, M. J., Wierda, D. {1986) in: Modern Pharmacology {Second

edition) {Craig, C. R., Stitzel, R. E. eds) pp-833, Little Brown and

company, Boston

198. Reddy GK, Chandraksan G, Dhar SC. Studies on the metabolism of

glycosaminoglycan under the influence of new herbal antiinflammatory

agents Biochem. Pharm 1989; 38: 3527-3534.

199. Reed, D.W., Bradshaw, W.S., Xie, W. and Simmons D. L.,

Prostaglandins. {1996), 52, 269-284.

200. Reitman, S., Frankel, S., {1957)Amer. J. Clin. Path. 28: 56.

201. Ribes G, Sauvaire Y, Baccou JC, et al., Effects of fenugreek seeds on

endocrine pancreatic secretions in dogs. Ann Nutr Metab. 1984; 28:

37-43.

202. Robertson RP. Arachidonic acid metabolites relevant to medicine. In:

Braunwald E, lsselbacher KJ, Petersdorf RG, eds. Harrison's

Principlesoflntemal Medicine. 11 ed. New York. McGraw-hill; 1987:375.

203. Robinson and J. R. Vane. Eds. {Raven. New York. 1974). pp.107-119.

204. Rovetta G (1991 ). Drugs in Experimental & Clinical Research; 53).

205. Ryan ME, A Robert. Greenwald, Golub LM. Potential ofteracyclines to

mody cartilage breakdown in osteoarthritis. Courrent Opinion Reheumatol

1996; 8:238-247.

206. S. Bergstrom. Nord. Med. 42. 1465 {1949). J. Sjovall. Acta. Chern.

Scand. 11. 1086 (1957): S. Bergstrom. L. Krabisch. J. Sjovall.lbid 14.

1706 (1960): S. Bergstrom and J. Sjovall. Ibid. p. 1701.

207. S. H. Ferreira and J.P. Vane. Annu. Rev. Pharmacal. 14. 57 {1974).

208. S. H. Ferreira and M. Nakamura. Prostaglandins 18. 179 (1979).

209. S. Hammarstrom. J. Bioi. Chern. 255.518 (1980).

210. S. I. Murata. M. Kawamura. I. Morita. Biochem. Biophys. Acta 528.

507 (1978); J. Morley M.A. Bray. R. W. Jones. D. H. Nugteren. D. A.

van Dorp. Prostaglandins 17.730 (1979). 186


211. S. L. Hong and L. Levine. J. Bioi. Chern. 251.5814 (1976).

212. S. Moncada. R. Gryglewski. S. Bunting. J. R. Vane. Nature (London)

263.663 (1976).

213. S. R. Turner and W. S. Lynn, in Leukocyte Chemotaxis. J. I. Gillin and

P. G. Quie Eds.(Raven, New York. 1978). pp. 289-298.

214. S. Rittenhouse-Simmons. J. Ciin.lnvest. 63. 580(1979): R. L. Bell. D.

A. Kennerly. N. Stanford. P. W. Majerus Proc. Natl. Acad. Sci. U.S.A

76. 3238 (1979): E G. Lapetina and P Cuatrecases.Biochem. Biophys.

Acta 573. 394 (1979).

215. Safayhi H, MackT, SabieraiJ., Boswellicacids: novel, specificnonredox

inhibitors of 5-lipoxygenase J. Pharmac. Exp. Ther. 1992; 261:

1143-1146.

216. Safayhi H, Rail B. Sailer ER, Ammon HPT. Inhibition by Boswellic

acids of human leukocyte elastase. J. Pharmacal Exp. Ther. 1997;

281:460-463.

217. Safayhi H., J. Pharm. Expt. Ther. 1992; 261: 1143.

218. Santhakumari G., Gujral M. L. and Sareen K., Indian J. Physiol.

Pharmacal, 8, 36,1964.

219. Satyavati G. V, Dwarkanath C. and Tripathi S. N, Indian J. Med. Res.

57. 1950.

220. Sawdy, R., Slater, D., Fisk, N., Edmonds, O.K., Bennett, P. (1997) Use

of COX type 2 selective non-steroidal anti-inflammatory agent to

prevent preterm delivery. Lancet 350: 256-266.

221. Sawdy, R., Stater, D., Fisk, N., Edmonds, D. K. and Bennett, P.,

(1977), 350. 265-266.

222. Saxena, R., Garg, K. C, Gupta, G. P. and Bhargava, K, P. Ind. J. Med.

Profes., (1965}, 12,5487.

223. Schleimer, R. P.:Ann. Rev. Pharmacal. Toxicol 25,381, (1985).

187


224. Schmassmann, A., Peskar, B. M., Stettler, C, Netzer, P., Stroff T.,

Flogerzi, B , Halter, F. (1998) Effect of inhibition of prostaglandin

endoperoxide synthase-2 in chronic gastrointestinal ulcer in rats. Br. J.

Pharmacol123:795-804.

225. Schorlemmer H. U. Kurrle R. Schleyerbach R. Bartlelt R. R. (1999).

Disease - modifying activity of malononinitrilamides, derivatives of

lefluonomides active metabolite on models of rheumatoid arthritis.

lnflamm. Res. 48. suppl2: S113-S114.

226. Selye, H. Proc. Soc. Exp Bio/. Med, (1953), 83, 328.

227. Sener B. and Bingol F., Int. J. Crude Drug. Res., 26(4}, 197, 1988.

228. Setnikar I, Palumbo P, Canali S, Zanola G. Pharmacokinetics of

glucosamine in man.Arzneim Forsch (Germany); 43:1109-13. (1993)

36:729-733.

229. Shah C. S. and Qadry J. S. (1985). A text book of Pharmacognosy,

Pub: M/s. B.S. Shah Ahmedabad. PP. 291-293.

230. Shani J., GoldschmiedA., Joseph E.,Ahronson, Z and Sulmar F. G.,

Arch. Int. Pharma. Codgn. Therp. 210 (1). 1974,20-37, Chem.Abstr.

83 (1975).

231. Sharma J. N., Rajpal M. N., Rao T. S. and Gupta S. K., Indian Drugs.

25 (6), 220, 1988.

232. Sharma ML, Bani S, Singh GB., Anti-arthritic activity of boswellic acid

in bovine serum albumin-induced arthritis. In J lmmunopharmac 1989;

6:647-652.

233. Sharma ML, Khajuria A, Kaul A., Effects of salai guggal extract of

Boswellia serrata on cellular and humoral immune responses and

leukocyte migration. Agents and Actions 1988; 24 (1-2): 161-164.

234. Sharma R. D., An Evaluation of hypocholesterolaemic factor of

Fenugreek (T. Foemum Graecum} in rats. Nutr. Rep. Int. 1986;33:

669-77.

188


235. Sharma R. D., Effect of Fenugreek seed and levels on blood glucose

and serum insulin responses in human subjects. Nutr. Res. 1986; 6:

1353-64.

236. Sharma R. D., Raghuram T. C. Rao N. S., Effect offenugreek seeds

on blood glucose and serum lipids in type-1 diabetes, Eur. J. Clin. Nutr.

1990; 44: 301-6.

237. Sharma R. D., Raghuram T. C, Hypoglycaemic effect of fenugreek

seeds in non-insulin dependent diabetic subjects. Nutr. lies. 1990; 1 0:

731-9.

238. Siddiqui H. H., Indian J. Pharm, 27, 80, 1965.

239. Simon, I. S., Curr. Opin Rheumatol. (1996), 8, 169-175.

240. Simonson. J. L. and Owen, L. N. Vol. 2. (1949). The Terpenes

University Press Cambridge P-1 0.

241. Simpson R. W., Mann Jl, Hockaday J. M. Turner R. C, Jelfs R. Lipid

abnormalities in untreated maturity onset diabetics and the effect of

treatment, Diabetologia 1979,16:101-106.

242. Singh G. B, Singh B. and Atal C. K., Indian. J. Pharmacal, 1984, 16,

51.

243. Singh S. and Majumdar OK., Indian J. Pharmacal, (1995), 28 (1 ), 45.

244. Singh S. and Majumdar D K, Can. J. Physic. Pharmacal. (1994), 72,

226.

245. Singh S. and Majumdar D K, Inflammation Res. (1995) 44, 268.

246. Singh S. and Majumdar D K, Int. J. Pharmacog. (1995), 33, 288.

247. Singh S. and Majumdar D K, New Botanist. (1994), 21, 139.

248. Singh S., Majumdar D K and Singh J. P.Jndian Vet. J. (1995), 72,867.

249. Singhal P. C, Gupta R. K., Joshi L. D., Hypocholcsteroloacmic effect

ofTrigonella foenum- raecum. Curr. Sci, 1982; 51: 136-7.

189

1


250. Singhal PC, Gupta RK, Joshi LD. Hypocholesterolemic effect of

Trigonellafoenum-graecum (METHI). CurrSci .1982:51:136.

251. Smith, M. J. H., Ford-Hutchinson, A. W., Elliot, P. N.C. and Bolam, J.

P. (1974). Pharm. Pharmac., 26,692.

252. Snydeman, R. in: The Medical Clinics of North America Advances in

Rheumatology, (Snyderman, R. ed) W.B. Saunders Company,

Philadelphia. 217, (1986)

253. Snyderman, R. (1986) in: The Medical clinics of North

America,(R.Snydermaned) W.B. Sa under company, Philadelphia.

254. Snyderman, R. (1988) in: Cecil Textbook of Medicine (Wyngaarden,

J. B, Smith, I. H.eds.) W.B. Saunder company, Philadelphia.

255. Sofia, R. D., Knobloch. L. C. and Vassar, H. B. (1975). J. Pharmac.

Exp. Ther. 193,918.

256. Solchaga LA, Dennis JE, Goldberg VM, Caplan AI, Hyluronic

acid-based polymers as cell carriers for tissue-Engineered repair of

bone and cartilage. J Orthop Res 1999; 17:205-213.

257. Spector, W. G., and Willoughby, D. A.: Bacterial. Rev. 27: 117-154

1963.

258. Sreejayan and M.N. Rao Nitric oxide Scavenging by Curcuminoids J.

Pharm. Pharmacal. (1997),49: 105-107.

259. Srimal R. C. and Dhawan B. N., J. Pharm, Pharmacal. 25 (1973)447.

260. Srimal R. C. and Dhwan B. N., J. Pharm. Pharmacal. 25,447, 1973.

261. Srimal R. C., Khanna, N. M. and Dhawan B. N., Indian J. Pharmacal, 3

(1971) 10.

262. Srimal, R. C., Khanna, N. M. and Dhawan, B N., Indian J. Pharmacal.,

(1971), 3, 10.

263. Srinivasan K. et al. (2005). "Plant foods in the management of diabetes

mellitus: spices as beneficial antidiabetic food adjuncts". International

Journal of Food Sciences and Nutrition 56 (6): 399-414. 190


264. Surendra Singh, Majumdar D. K Evaluation of anti-inflammtory activity

of fatty acids of Ccimum Sanctum fixed oil. Indian Journal of

Experimental Biology. Vol. 35, (1997), pp. 380-383.

265. Surendra Singh, Majumdar D. K. and Yadav M. R., Chemical and

Pharmacological studies on fixed oil of Ocimum Sanctum. Indian Journal

of Experimental Bidogy. Vol. 3-1, (1996), pp.1212-1215.

266. Surendrakumar, P and Sadique J, Fitoterapia. Vol LVIII, No.6 (1987)

379.

267. Sur P, Das M, Gomes A, et al. Trigonella foenum graecum (fenugreek)

seed extract as an antineoplastic agent. Phytother Res. 2001 ;15:

257-259.

268. Swingle, K.F., Kvam S.C. in : Modern Pharmacology, (Craig, C. R.

Sliizel, R.b.,-cd), Little Brown and Company, Boston, 1028,1982.

269. Swingle, K.F., Kvam, D.C. (1986) in: Modern Pharmacology (Second

Edition) (Criag, C.R, Stitzel, R.E.eds) pp-1028 Little Brown company,

Boston.

270. T. Miyamoto. K. Taniguchi. T. Tanouchi. F. Hirata. Adv. Prostaglandin

Thromboxand Res. 6. 443 (1980).

271. TadaA., Kaneiwa Y, Shoji J. and Shibata S., Chern Pharm. Bull, 23,

2965,1975

272. Tagahara K., Suzuta Y, Kiniwa M., and Unemi N., Shoyakuyaku Zosshi,

36(4 ), 370, 1982.

273. Takagi K. and Lee E. B., YakugakuZasshi, 92,961,1972.

274. Taurgo, J.D., Kerwar, S., McReynolds, R. A., 1985. J. Exp. Medicine

16.2962.

275. The Wealth of Asia, P.I.D., C.S.I.R., 1996, New Delhi. (CD Version)

276. Thirunavukkarasu V. et al. (2003). "Protective effect of fenugreek

(Trigonella foenum graecum) seeds in experimental ethanol toxicity".

Phytother Res 17 (7): 737-7 43.

191


277. TschirchA., Halbey 0., (1898). Arch. Pharma., 236,487.

278. Vago, T. Bevilacqua, M, Norbiato, G.(1995) Effectofnimesulide action

time depencence on selectivity towards prostaglandin G/H synthase/

COXactivity.Arzneim. Forsch. 45:1096-4098

279. Valette G., Sauvaire Y, Beccou J. C. Ribes G., Hypocholesterolaemic

effect of fenugreek seeds in dogs. Atherosclerosis 1984,50: 105-11.

280. Valette G, Sauvaire Y, Baccou JC, Ribes G. Hypocholesterolaemic

effect of fenugreek seeds in dogs. Atherosclerosis . 1984;50: 1 05-111.

281. Vander Oudera, F. J., Buytenhek, M., Nugteren, D. H. and Van Dorp.,

D. A. Eur. J. Biochem. 1980109, 1-8.

282. Vane, J. R. and Botting, R. M, Scand. J. Rheumatol (Suppl. 102),

(1996). 25, 9-21.

283. Vane, J. R., Bakhle, Y. S. and Botting, R. M., Annu. Rev. Pharmacal.

Toxicol (1998), 38,97-120.

284. Vane, J. R., Flower. R. J. and Botting, R.M., Stroke (Suppi.IV) (1990),

21,12-23.

285. Vane, J. R., Nature, (1971 ), 231.232-235.

286. Vane J. Towards a betters aspirin. Nature, 1994, 367: 215-216.

287. Vats V. Yadav SP, Biswas NR, Grover JK. Anti-cataract activity of

Pterocarpus marsupium bark and Trigonella Foenum-graecum seeds

extract in alloxan diabetic rats. J Ethnopharmacol. 2004; 93: 289-294.

288. W. L. Smith and W. E. M. Lands. Biochemistry 11. 3276 (1972).

289. Wallace J. L. Reuter, B. K., McKnight, W., Bak, A. (1998) selective

inhibitor of COX-2: are they really effective, selective and Gl safe ?

27: S28-S34.

290. Wallace, J. L., Tips (1999), 20, 4-6.

291. Wallace, J. L., (1992) Prostaglandins, NSAIDs and cytoprotection.

Gastrointest. Pharmacal 21 :631-641

192


292. Wallis T. E (1985) Text Book of Pharmacognosy, 5th Edition (First

Indian Edition) Pub: C. B. S. Publishers and Distributors, Delhi P. P.

224-225

293. Wealth of Asia 1996.

294. Weinblatt, M. E. (1987). J. Rheumatoid 14, 859.

295. Whitehouse, M. M, progress in Drug Research, Vol. 8, Birkhauser

Verlag, Basel, (1965), p. 321.

296. Whittle, B. J. R. (1976} Relation between prevention of rat gastric

erosions and the inhibition of acid secretion by prostaglandins. Eru. J.

Pharmacal. 40: 233-239

297. Wilkens, R. F. (1987).TheAmerican J. Medicine 83 (S48) 31.

298. Willoughby, D.A., Moore, A. R., and Colville-Nask, P.R., lancet, (2000).

355. 646-648.

299. Winter, C. A., Risley, E. A. and Nuss, G. W. J. Pharmacal. Expt. ther.,

(1963), 1411 369.

300. Winter, CA., Risley. E. A. and Nuss, G. W. Proc. Soc. Exp. Bioi. Med., (1962), 111, 544.

301. Yadav UC, Moorthy K, Baquer NZ. Effects of sodium-orthovanadate

and Trigonella foenum-graecum seeds on hepatic and renal lipogenic

enzymes and lipid profile during alloxan diabetes. J. Biosci. 2004; 29: 81-91.

302. Yegnanarayan R., SarafA. P. and Balwani J. H., Indian. J. Med. Res. 64, 601 11976

303. Ziboh, VA and Chapikin R S, Arch Dermatol, 123 (1987) 1686.

304. Zurier, B., Ann. Rheum. Dis. 50 (1991) 745.

1i11111r 12930

193

Documents

Chapter 7shodhganga.inflibnet.ac.in/bitstream/10603/33483/14/14... · · 2015-01-28Bhattacharya T. K., Ghosh M. N. and Subramanian S. S ... and therapeutic strategies for prevention